Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-31

Clinical Trial Update: Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating hyperemia with ocular prostaglandin analogues in open angle glaucoma and ocular hypertension; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified ocular prostaglandin analogue

Snippet

Sponsor: Allergan | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-10-31